Grant: Discovery Grants Program - Individual
University of Waterloo
$28,000.00
Next-Generation Enabling Technologies Towards Precision and Personalized Medicine
FY 2024-25
Summary
This research program aims to develop a generalizable, real-time biosensor to enable continuous monitoring of a diverse range of disease-related biomarkers, and to facilitate simultaneous delivery of the right drug dosage. This integrated device will eventually enable truly personalized medicine through continuous monitoring of individual patient conditions, allowing physicians to tailor specific medical treatments to an individual's unique molecular and/or genetic profile. Real-time monitoring faces exceptional challenges: 1) A tiny volume of complex biofluids must be handled; 2) High sensitivity and specificity are required; 3) The platform must be generalizable to various analytes; 4) Multiplexed measurements must be performed; and 5) The biosensor must be implemented as a point-of-care platform for bedside monitoring. Due to these unmet challenges, currently, there is no sensor technology that can measure multiple disease biomarkers directly in whole blood and in real-time and simultaneously administer the right drug dosage at the right time.
This research program will develop a new platform that meets these challenges, where novel microfluidic techniques will be combined with advanced optical imaging. The platform is called "RT-Sensing&Delivery" as it consists of two main modules: sensing and drug delivery. We will pursue three integrated objectives to achieve our goals: O1. Design and implementation of the "sensing module"; O2. Creating an automated and robust "drug delivery module"; O3. Expanding the multiplexed capability of the platform. These short-term goals will be important to the attainment of our long-term goal of advancing the field of personalized medicine through a universal biosensor platform which continuously tracks and detects multiple disease-related biomarkers' fluctuating concentration levels and achieves precise and personalized drug dosing. The RT-Sensing&Delivery device will consequently enable many potentially transformative applications in medicine as it introduces a general tool for measuring proteins, small molecules and other biomolecules and can be implemented in the biomedical research such as infectious diseases, neuroscience, immunology, cancer, and others. It also helps to maintain high quality healthcare in Canada, where healthcare costs contribute to more than 10% of the gross domestic product. This research program will contribute to the training of next generation of innovators and pioneers in the field of biomedical engineering and provide students with the required technical and soft skillsets (i.e., micro/nanotechnology techniques, device fabrication, molecular analysis, information processing, circuit design, optical imaging, rational thinking to solve problems, managing and leading individual projects, and collaboration) to take roles in industry, academic research, and entrepreneurship
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-04434
Name nom
Poudineh, Mahla
Department département
Electrical and Computer Engineering
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Next-Generation Enabling Technologies Towards Precision and Personalized Medicine
Keywords
real-time and continuous monitoring; integrated biosensor; generalizable platform; microfluidics; optical monitoring; multiplexing; whole blood handling; personalized medicine; early diagnosis; effective treatment
Application summary
This research program aims to develop a generalizable, real-time biosensor to enable continuous monitoring of a diverse range of disease-related biomarkers, and to facilitate simultaneous delivery of the right drug dosage. This integrated device will eventually enable truly personalized medicine through continuous monitoring of individual patient conditions, allowing physicians to tailor specific medical treatments to an individual's unique molecular and/or genetic profile. Real-time monitoring faces exceptional challenges: 1) A tiny volume of complex biofluids must be handled; 2) High sensitivity and specificity are required; 3) The platform must be generalizable to various analytes; 4) Multiplexed measurements must be performed; and 5) The biosensor must be implemented as a point-of-care platform for bedside monitoring. Due to these unmet challenges, currently, there is no sensor technology that can measure multiple disease biomarkers directly in whole blood and in real-time and simultaneously administer the right drug dosage at the right time.
This research program will develop a new platform that meets these challenges, where novel microfluidic techniques will be combined with advanced optical imaging. The platform is called "RT-Sensing&Delivery" as it consists of two main modules: sensing and drug delivery. We will pursue three integrated objectives to achieve our goals: O1. Design and implementation of the "sensing module"; O2. Creating an automated and robust "drug delivery module"; O3. Expanding the multiplexed capability of the platform. These short-term goals will be important to the attainment of our long-term goal of advancing the field of personalized medicine through a universal biosensor platform which continuously tracks and detects multiple disease-related biomarkers' fluctuating concentration levels and achieves precise and personalized drug dosing. The RT-Sensing&Delivery device will consequently enable many potentially transformative applications in medicine as it introduces a general tool for measuring proteins, small molecules and other biomolecules and can be implemented in the biomedical research such as infectious diseases, neuroscience, immunology, cancer, and others. It also helps to maintain high quality healthcare in Canada, where healthcare costs contribute to more than 10% of the gross domestic product. This research program will contribute to the training of next generation of innovators and pioneers in the field of biomedical engineering and provide students with the required technical and soft skillsets (i.e., micro/nanotechnology techniques, device fabrication, molecular analysis, information processing, circuit design, optical imaging, rational thinking to solve problems, managing and leading individual projects, and collaboration) to take roles in industry, academic research, and entrepreneurship